[1]
S. A. El Wahed, N. F. Hassabou, and M. A. Hamouda, “Anticancer Potential of Hesperidin against HEp-2 Laryngeal Carcinoma Cell Line in Comparison to Doxorubicin”, Open Access Maced J Med Sci, vol. 10, no. A, pp. 1300–1309, Jul. 2022.